Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wendling

Showing results (1-10 of 496) with videos related to

Pageof 50
Sort By:
Joint Bone Spine|May 7, 2016
The gut in spondyloarthritisDaniel Wendling
Joint Bone Spine|December 9, 2022
Sacro iliac synostosisDaniel Wendling
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 7, 2023
Interleukin-23 Blockade Is Not Effective in Axial SpondyloarthritisDaniel Wendling
Joint Bone Spine|October 11, 2005
Interleukin-1: a new therapeutic target for ankylosing spondylitis?Daniel Wendling
Joint Bone Spine|June 4, 2023
Spyglass thumbDaniel Wendling
Joint Bone Spine|December 12, 2003
Anti-TNF alpha therapy in spondyloarthropathy: deciding who to treatDaniel Wendling
Bulletin De L'Academie Nationale De Medecine|June 8, 2018
Involvement of Th 17 pathway in spondyloarthritisDaniel Wendling
Joint Bone Spine|June 20, 2019
Local sacroiliac injections in the treatment of spondyloarthritis. What is the evidence?Daniel Wendling
Joint Bone Spine|June 26, 2007
Biologics in the treatment of primary inflammatory myositisDaniel Wendling
Joint Bone Spine|September 26, 2008
Interleukin 23: a key cytokine in chronic inflammatory diseaseDaniel Wendling
Pageof 50

Showing results (1-10 of 496) with videos related to

Sort By:
Pageof 50
Joint Bone Spine|May 7, 2016
The gut in spondyloarthritisDaniel Wendling
Joint Bone Spine|December 9, 2022
Sacro iliac synostosisDaniel Wendling
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 7, 2023
Interleukin-23 Blockade Is Not Effective in Axial SpondyloarthritisDaniel Wendling
Joint Bone Spine|October 11, 2005
Interleukin-1: a new therapeutic target for ankylosing spondylitis?Daniel Wendling
Joint Bone Spine|June 4, 2023
Spyglass thumbDaniel Wendling
Joint Bone Spine|December 12, 2003
Anti-TNF alpha therapy in spondyloarthropathy: deciding who to treatDaniel Wendling
Bulletin De L'Academie Nationale De Medecine|June 8, 2018
Involvement of Th 17 pathway in spondyloarthritisDaniel Wendling
Joint Bone Spine|June 20, 2019
Local sacroiliac injections in the treatment of spondyloarthritis. What is the evidence?Daniel Wendling
Joint Bone Spine|June 26, 2007
Biologics in the treatment of primary inflammatory myositisDaniel Wendling
Joint Bone Spine|September 26, 2008
Interleukin 23: a key cytokine in chronic inflammatory diseaseDaniel Wendling
Pageof 50